Additional tumor-associated receptors in HNSCC include integrin beta-6 (ITGB6), a component implicated in tumor invasiveness and frequently overexpressed in HNSCC, where its expression is associated with poor clinical outcomes [143]. Here, ITGB6 is linked to neoplasm.